Lee Ainslie’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.41M Buy
+50,975
New +$2.62M 0.02% 70
2023
Q4
Sell
-23,172
Closed -$1.33M 429
2023
Q3
$1.33M Sell
23,172
-1,296
-5% -$78.3K 0.03% 102
2023
Q2
$1.45M Buy
24,468
+18,028
+280% +$1.08M 0.03% 125
2023
Q1
$403K Sell
6,440
-19,541
-75% -$1.22M 0.01% 347
2022
Q4
$1.63M Buy
25,981
+8,781
+51% +$504K 0.04% 110
2022
Q3
$857K Sell
17,200
-1,904
-10% -$105K 0.02% 142
2022
Q2
$1.12M Sell
19,104
-1,416
-7% -$78.1K 0.03% 132
2022
Q1
$1.09M Buy
+20,520
New +$1.18M 0.02% 134
2021
Q4
Sell
-54,545
Closed -$3.06M 550
2021
Q3
$3.06M Buy
+54,545
New +$3M 0.03% 137
2020
Q2
Sell
-33,213
Closed -$1.22M 647
2020
Q1
$1.22M Buy
+33,213
New +$1.29M 0.03% 273
2019
Q4
Sell
-197,352
Closed -$6.85M 403
2019
Q3
$6.85M Buy
197,352
+121,162
+159% +$3.99M 0.1% 86
2019
Q2
$2.41M Buy
+76,190
New +$2.26M 0.04% 224

Other funds holding PBH

Lee Ainslie's PBH Position: Q2 2026 in Review

Lee Ainslie opened a new position in Prestige Consumer Healthcare (PBH) in Q2 2026: 50,975 shares worth $2.41M. The stake represents 0.02% of the portfolio and ranks #70 among its holdings. This is a return to the name: Lee Ainslie previously reported a position in PBH as recently as Q3 2023.

Lee Ainslie first reported a position in PBH in Q2 2019 and has held it in 12 quarters since. The position peaked at $6.85M in Q3 2019. 318 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Lee Ainslie held 50,975 shares of Prestige Consumer Healthcare worth $2.41M as of Q2 2026.
  • Prestige Consumer Healthcare was a new Lee Ainslie position in Q2 2026.
  • Prestige Consumer Healthcare made up 0.02% of Lee Ainslie's portfolio in Q2 2026, its #70 holding.
  • Lee Ainslie first reported a position in Prestige Consumer Healthcare in Q2 2019 and has held it in 12 quarters since.
  • Lee Ainslie's Prestige Consumer Healthcare position peaked at $6.85M in Q3 2019.
  • 318 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Maverick Capital's 13F filing for Q2 2026, filed 14 Aug 2026.